Endocyte Retreats ( ECYT, CISCO, LVLT, SZYM )

Endocyte Turns Lower on High Volatility (ECYT, CISCO, LVLT, SZYM)
 
Endocyte Inc (NASDAQ:ECYT) shares are showing very volatile moves in today’s session after rising over 58% in the previous trading session on news that the company is planning to submit conditional marketing-authorization applications for its ovarian cancer treatment in Europe in the third quarter after meeting with European health authorities.
 
The stock gapped up over 10% this morning, but moved back below yesterday’s closing price on profit booking with more than 4.16 million shares changed hands so far. Late Tuesday, the company reported a loss of 30 cents a share in its fourth quarter, topping analysts’ estimates by 4 cents. The stock is now trading lower by 0.50% to $5.87.
 
Cisco Systems Inc (NASDAQ:CSCO) shares slid 1.11% to $19.97 after the company reached a deal to acquire NDS Group Ltd. Under the terms of the agreement, Cisco will pay around $5 billion to acquire all of the business and operations of NDS. The acquisition is expected to close during the second half of calendar year 2012.
 
Level 3 Communications Inc (NYSE:LVLT) shares continued to move higher and was recently higher by 5.10% at $26.20. This morning analyst at raised their investment rating on the stock to Buy from Neutral and set a price target of $37.50, which is still showing potential gain of over 43%, stating favourable risk/reward ratio. The firm also expects strong set of results from the company, which should trigger the stock higher.
 
Solazyme Inc (NASDAQ:SZYM) continued to surge and extended its week long rally to over 23%, including today’s gain of over 7%. The stock has been gaining since the start of this week on rumours that its relationship with the U.S. Defense Department will grow even as some of its raw material costs surge. The Defense Department released a report last week that highlighted “a strong interest in securing non-petroleum sources of fuel.”
 
Also, earlier this week, Mad Money’s Jim Cramer provided positive comments on the stock, citing company’s game plan of transforming a range of plant-based sugars into oils has drawn increasing interest as oil prices linger at high levels.